Why the study?
Does central sympathetic blockade with dexamethasone alter insulin-mediated coronary flow reserve in men with type 1 diabetes?
RCT (n=21)
Random order crossover
No
Does central sympathetic blockade with dexamethasone alter insulin-mediated coronary flow reserve in men with type 1 diabetes?
Answers are grounded in this paper and cite their sources.
Sympathetic activation plays an important role in regulating insulin's effects on myocardial perfusion in patients with type 1 diabetes, as central sympathetic blockade with dexamethasone abolishes insulin-induced increases in coronary flow reserve.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Swallow et al. (2004) conducted an RCT in Type 1 diabetes (n=21). Dexamethasone vs. No dexamethasone was evaluated on Insulin-stimulated coronary flow reserve (p=<0.05).
Synapse has enriched 10 related papers. Consider them for comparative context: